Wilhelm den Toom
Overview
Explore the profile of Wilhelm den Toom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
den Toom W, Negenman E, Willemssen F, van Werkhoven E, Porte R, de Wilde R, et al.
Clin Transl Radiat Oncol
. 2024 Nov;
49:100878.
PMID: 39512948
Purpose/objectives: To evaluate if stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC) has a durable effect on tumor control and can be delivered safely. Materials/methods: Patients included in this retrospective...
2.
Fleury E, Pignol J, Kilic E, Milder M, van Rij C, Naus N, et al.
Phys Imaging Radiat Oncol
. 2024 Jul;
31:100605.
PMID: 39050744
Background And Purpose: Uveal melanoma (UM) is the most common primary ocular malignancy. We compared fractionated stereotactic radiotherapy (SRT) with proton therapy, including toxicity risks for UM patients. Materials And...
3.
Mendez Romero A, van der Holt B, Willemssen F, de Man R, Heijmen B, Habraken S, et al.
Int J Radiat Oncol Biol Phys
. 2023 Apr;
117(1):45-52.
PMID: 37037359
Purpose: To compare transarterial chemoembolization delivered with drug eluting beads (TACE-DEB) with stereotactioc body radiation therapy (SBRT) in patients with hepatocellular carcinoma (HCC) in a multicenter randomized trial. Methods And...
4.
Paronetto C, den Toom W, Milder M, van Norden Y, Baak R, Heijmen B, et al.
Front Oncol
. 2023 Mar;
13:1114737.
PMID: 36969072
Using fiducial-marker-based robotic respiratory tumor tracking, we treated perihilar cholangiocarcinoma patients in the STRONG trial with 15 daily fractions of 4 Gy. For each of the included patients, in-room diagnostic-quality...
5.
Milder M, Magallon-Baro A, den Toom W, de Klerck E, Luthart L, Nuyttens J, et al.
Phys Imaging Radiat Oncol
. 2022 Aug;
23:103-108.
PMID: 35928600
Background And Purpose: Stereotactic body radiotherapy (SBRT) has been proven to be beneficial for several disease sites in the (lower) abdomen. However, the quality of the treatment plan, based on...
6.
Magallon-Baro A, Milder M, Granton P, den Toom W, Nuyttens J, Hoogeman M
Front Oncol
. 2022 Jun;
12:910792.
PMID: 35756687
Purpose: To determine the dosimetric impact of using unedited autocontours in daily plan adaptation of patients with locally advanced pancreatic cancer (LAPC) treated with stereotactic body radiotherapy using tumor tracking....
7.
Baak R, Willemssen F, van Norden Y, Eskens F, Milder M, Heijmen B, et al.
Cancers (Basel)
. 2021 Aug;
13(16).
PMID: 34439146
Background: In unresectable pCCA, the standard of care is palliative chemotherapy. We investigated the feasibility and safety of adding stereotactic body radiation therapy (SBRT) after chemotherapy. Methods: Patients with unresectable...
8.
Gizynska M, Rossi L, den Toom W, Milder M, de Vries K, Nuyttens J, et al.
J Appl Clin Med Phys
. 2021 Jan;
22(3):35-47.
PMID: 33475227
Recently, VOLO™ was introduced as a new optimizer for CyberKnife® planning. In this study, we investigated possibilities to improve treatment plans for MLC-based prostate SBRT with enhanced peripheral zone dose...
9.
Moustakis C, Chan M, Kim J, Nilsson J, Bergman A, Bichay T, et al.
Strahlenther Onkol
. 2018 May;
194(9):843-854.
PMID: 29802435
Purpose: To investigate the quality of treatment plans of spinal radiosurgery derived from different planning and delivery systems. The comparisons include robotic delivery and intensity modulated arc therapy (IMAT) approaches....